Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.020
-0.030 (-1.46%)
At close: Jun 18, 2026, 4:00 PM EDT
2.050
+0.030 (1.49%)
After-hours: Jun 18, 2026, 7:40 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $363.78 million as of June 18, 2026. Its market cap has increased by 21.23% in one year.
Market Cap
363.78M
Enterprise Value
178.88M
1-Year Change
21.23%
Ranking
Category
Stock Price
$2.02
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $363.78M, a decrease of -16.44%. That is a compound annual growth rate of -3.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 363.78M | -61.91% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 388.68M |
| Benitec Biopharma | 388.55M |
| Larimar Therapeutics | 388.30M |
| X4 Pharmaceuticals | 382.94M |
| Editas Medicine | 375.98M |
| Greenwich LifeSciences | 370.77M |
| Enanta Pharmaceuticals | 367.70M |
| Puma Biotechnology | 367.49M |